Scottsdale - HonorHealth Research Institute - Medical Oncologists with interest
Company: HonorHealth
Location: Scottsdale
Posted on: September 21, 2024
|
|
Job Description:
HonorHealth Research Institute in Collaboration with HonorHealth
Health Care SystemScottsdale, Arizona The Division of Cancer
Research is seeking Board Certified Medical Oncologist with
clinical research expertise/interest in the following areas:
Melanoma and Solid Tumor Cellular Therapy to join a Cutaneous
Oncology ProgramPancreatic cancer / GI malignanciesWomen's Cancer
Research Program lead for the Drug Development ProgramBMT/Cellular
Therapies Program Join the preeminent phase 1 oncology drug
development program in the Southwest US HonorHealth Research
Institute (HRI)Established in 2005, the HonorHealth Research
Institute (HRI) is part of a six-hospital not-for-profit integrated
healthcare system in the Scottsdale/Phoenix metro area. The HRI
Cancer Research Division is affiliated with HonorHealth Cancer Care
which is a multi-disciplinary Cancer Care program and delivers
primary cancer care to approximately 1/3 of all newly diagnosed
cancer patients in the Phoenix metropolitan area.As a partner with
the regions only locally owned, locally managed healthcare system
with an expansive cancer care footprint, HRI is dedicated to
offering patients thoughtful, compassionate care and access to
novel treatments through innovative clinical research. The focus of
the Division of Cancer Research is on providing access to new and
novel clinical trials for patients with relapsed and refractory
cancer within the state of Arizona and across the United States.
Our collaborators include global biopharmaceutical, biotechnology,
medical device, and clinical research organizations.2023
Highlights:
1) Comprehensive Pancreatic Cancer Program delivering
multi-specialty care from new diagnosis through relapsed and
refractory disease
2) Cutaneous Oncology Program delivering comprehensive care to
patients with various melanoma and nonmelanoma skin cancers
including uveal melanoma and
3) Phase 1 program including approximately 50-60 active Phase 1
trials of new targeted drugs, immunotherapeutic agents,
chemotherapeutics, bispecific antibody therapy and radioligand
trials.HRI Clinical Research Oncologists benefit from being a part
of a community-based research program which has access to
additional resources with reduced administrative layers and
generous philanthropic support. Faculty have the opportunity to
join the University of Arizona College of Medicine-Phoenix as
adjunct faculty where they serve as preceptors and lecturers for
clinical rotations and pre-clinical courses. Melanoma/Solid Tumor
Cell Therapy Research Position HRI is seeking a Board-Certified
Oncologist to the join the Melanoma and Solid tumor Cellular
Therapy Program which sees patients with all types of advanced
cutaneous malignancies for both standard of care and clinical trial
treatments in collaboration with the HonorHealth Dermatology
Residency Program. The program has a special focus on uveal/ocular
melanoma with multiple clinical trials and translational research
programs focused on this rare tumor. The Research Oncologist will
partner with the Melanoma Medical Oncologist and will independently
lead Phase 1 &2 clinical trials. The Clinical Research
Oncologist will also have the opportunities to participate in and
initiate their own translational research activities through
collaborations with the Translational Genomic Research Institute
(TGen), the University of Arizona (UArizona), Arizona State
University (ASU) as well as other regional and national
institutions. The successful candidate will have the opportunity to
lead early phase clinical trials and participate in novel cellular
therapy and bispecific antibody trials.Pancreatic Cancer Research
PositionHRI is seeking a Board-Certified Oncologist to join a
robust Pancreatic Cancer Research Program which offers
comprehensive options for treatment ranging from individuals with
newly diagnosed localized pancreatic cancer to those with advanced
refractory disease. The program has a focus on early detection of
pancreas cancer supported by being a center for PRECEDE and grants
from the NIH for the UO1/PCDC program. Additionally, HRI is a site
within the PANCAN precision promise consortium. The NCCN guideline
therapies of gemcitabine plus nab-paclitaxel, 5FU plus nano
liposomal irinotecan, and gemcitabine plus nab-paclitaxel, plus
cisplatin all originated at HRI. The successful candidate will have
the opportunity to lead pancreas cancer initiatives and work within
a multi-disciplinary team. Women's Cancer Research Position HRI is
seeking a Board-Certified Medical Oncologist to lead and expand the
drug development program for women's cancers including breast
cancer and gynecologic oncology malignancies. The successful
candidate will advance the existing Phase 2 & 3 Research Programs
led by community based board-certified gynecologic oncologists and
grow Phase 1 enterprises for patients with relapsed and refractory
disease. Bone Marrow Transplant (BMT)/Cellular Therapies
PositionHRI is seeking a Board-Certified Oncologist to partner with
the HonorHealth s BMT program to offer cellular therapy. BMT is a
24-bed unit which performs over 100 allogenic transplants a year.
This partnership provides the infrastructure to deliver cellular
therapy. Initiatives have already started in cutaneous oncology
with plans to move into solid and hematologic malignancies. The
successful candidate will engage with community hematology/oncology
partners in the Phoenix metropolitan area supporting expansion of
access to current bispecific antibody options for lymphoma and
multiple myeloma with a focus on disease or therapeutic approaches.
Responsibilities
Keywords: HonorHealth, Scottsdale , Scottsdale - HonorHealth Research Institute - Medical Oncologists with interest, Healthcare , Scottsdale, Arizona
Click
here to apply!
|